Prokidney 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Prokidney 's ROA in the second quarter of 2026?
Prokidney Corp recorded a cumulative net loss of $-166 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -54.43%.

However, within the Healthcare sector 580 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 3883, from total ROA ranking in the first quarter of 2026 at 4480.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	-32.33 %	-28.2 %	-24.24 %	-25.81 %	-25.34 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-166	-156	-152	-159	-164
Return On Assets (TTM)	-54.43 %	-46.76 %	-41.81 %	-40.92 %	-39.21 %
PROK's Total Ranking	# 3883	# 4480	# 3912	# 3928	# 3962
Total Assets (TTM) in million	249	289	332	348	368
Seq. Total Assets Change	-13.94 %	-12.82 %	-4.55 %	-5.5 %	-8.69 %
Seq. Net Income Change	-	-	-	-	-

PROK's 5 Years Annual ROA >> Back to PROK Management Effectiveness >> Compare PROK ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 79
Sector	# 581
Overall	# 3935

Return On Assets Statistics
High	Average	Low
-2.11 %	-32.23 %	-53.95 %
(Mar 31 2022)		(Jun 30 2026)

Financial Statements
Prokidney 's Assets	$ 249 million	PROK's Balance sheet
Prokidney 's Income	$ -46 million	Quarterly PROK's Income Statement
PROK's Income by Division		See PROK's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	-24.24 %	5.24 %	-19.27 %	105.27 %	-
Total Assets in million	332	438	416	516	251
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-152	-163	-135	-148	-2
Annual Return On Assets	-45.68 %	-37.28 %	-32.54 %	-28.73 %	-0.93 %

PROK's 5 Years Annual ROA >> Back to PROK Management Effectiveness >> Compare PROK ROA to its Competitors

More Return On Assets Ratios
PROK's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
PROK's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for PROK's Competitors
Subscribers only: Roa for Prokidney 's Suppliers
Subscribers only: Return On Assets for PROK's Customers

You may also want to know
PROK's Roi	PROK's Inventory Turnover Ratio	PROK's Growth Rates	PROK's Dividend Comparisons
	PROK's Profitability Ratios	PROK's Asset Turnover Ratio	PROK's Dividend Growth
PROK's Roe	PROK's Valuation Ratios	PROK's Financial Strength Ratios	PROK's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-12T06:25:36+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.